by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
ADVISORY, Sept. 08, 2016 (GLOBE NEWSWIRE) — What: Celgene Corporation (Nasdaq:CELG), an integrated global biopharmaceutical company, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Mark J. Alles, Chief Executive Officer, will ring the...
by GlobeNewsWire | Sep 8, 2016 | Canadian Stocks, Globe Newswire
BURNABY, British Columbia, Sept. 08, 2016 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced the pricing of a $30 million underwritten public offering of its common shares pursuant to its...
by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
HAYWARD, Calif., Sept. 08, 2016 (GLOBE NEWSWIRE) — Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announced that it has agreed to sell preferred convertible stock in two tranches to Biotechnology Value Fund, L.P. and other affiliates of BVF Partners L.P....
by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
BOTHELL, Wash., Sept. 08, 2016 (GLOBE NEWSWIRE) — Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced that data from Phase 2b and Phase 1 clinical trials of ALD403...
by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
BOSTON, Sept. 08, 2016 (GLOBE NEWSWIRE) — Albireo Limited, a clinical-stage company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases...